Physiologically-based pharmacokinetic modeling to predict the exposure and provide dosage regimens of Ustekinumab in pediatric patients with inflammatory bowel disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Physiologically-based pharmacokinetic modeling to predict the exposure and provide dosage regimens of Ustekinumab in pediatric patients with inflammatory bowel disease

Published:2024-08 Issue: Volume:199 Page:106807
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Cai Xiaoxi,Wu Wanhong,Guo Guimu,Chen Jiarui,Xu Jianwen,Lin WeiWei,Huang Pinfang,Lin Cuihong,Lin Rongfang^ORCID

Publisher

Elsevier BV

Reference58 articles.

1. Pharmacokinetics and exposure response relationships of Ustekinumab in patients with Crohn's disease [J];Adedokun;Gastroenterology,2018

2. Population pharmacokinetics and exposure-response analyses of ustekinumab in patients with moderately to severely active Crohn's disease [J];Adedokun;Clin. Ther.,2022

3. Ustekinumab Pharmacokinetics and exposure response in a phase 3 randomized trial of patients with ulcerative colitis [J];Adedokun;Clinic. Gastroenterol. Hepatol.,2020

4. Ustekinumab dosing individualization in Crohn's disease guided by a population pharmacokinetic–pharmacodynamic model [J];Aguiar Zdovc;Pharmaceutics.,2021

5. Neonatal FcR expression in bone marrow-derived cells functions to protect serum IgG from catabolism [J];Akilesh;J. Immunol.,2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP